Amerigen wins US FDA approval for generic Penicillamine in 250 mg capsules.

Global Banking News-May 10, 2019-Amerigen wins US FDA approval for generic Penicillamine in 250 mg capsules

(C)2019 ENPublishing - http://www.enpublishing.co.uk

Pharmaceutical group Amerigen Pharmaceuticals Limited reported on Friday the receipt of the US Food and Drug Administration's final approval for its Abbreviated New Drug Application (ANDA) for Penicillamine Capsules USP in 250 mg in the treatment of Wilson's disease, cystinuria and severe, active rheumatoid arthritis.

This is the first ANDA to be approved as a generic equivalent to Bausch Heath's Cuprimine.

Penicillamine Capsules USP in 250 mg have now been launched...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT